Hard To Treat Stock Current Asset
Hard to Treat fundamentals help investors to digest information that contributes to Hard To's financial success or failures. It also enables traders to predict the movement of Hard Stock. The fundamental analysis module provides a way to measure Hard To's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Hard To stock.
Other Current Assets is likely to drop to 9,727 in 2024. Total Current Assets is likely to drop to about 2.7 M in 2024. Hard | Current Asset |
Hard to Treat Company Current Asset Analysis
Hard To's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Hard To Current Asset | 596 K |
Most of Hard To's fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hard to Treat is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
Hard Total Assets
Total Assets |
|
In accordance with the recently published financial statements, Hard to Treat has a Current Asset of 596 K. This is 99.97% lower than that of the Biotechnology sector and 99.94% lower than that of the Health Care industry. The current asset for all United States stocks is 99.99% higher than that of the company.
Hard Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hard To's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Hard To could also be used in its relative valuation, which is a method of valuing Hard To by comparing valuation metrics of similar companies.Hard To is currently under evaluation in current asset category among its peers.
Hard Fundamentals
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 254.37 K | ||||
| Shares Outstanding | 5.48 B | ||||
| Price To Sales | 0.01 X | ||||
| Revenue | 5.39 M | ||||
| Gross Profit | 1.42 M | ||||
| EBITDA | 1.03 M | ||||
| Net Income | 621.6 K | ||||
| Cash And Equivalents | 202.9 K | ||||
| Total Debt | 1.54 M | ||||
| Debt To Equity | 0.21 % | ||||
| Current Ratio | 2.27 X | ||||
| Cash Flow From Operations | 655.71 K | ||||
| Beta | 0.27 | ||||
| Market Capitalization | 54.82 K | ||||
| Total Asset | 4.56 M | ||||
| Retained Earnings | 1.4 M | ||||
| Working Capital | (508 K) | ||||
| Current Asset | 596 K | ||||
| Current Liabilities | 1.1 M | ||||
| Net Asset | 4.56 M |
About Hard To Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hard to Treat's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hard To using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hard to Treat based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Hard Stock Analysis
When running Hard To's price analysis, check to measure Hard To's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hard To is operating at the current time. Most of Hard To's value examination focuses on studying past and present price action to predict the probability of Hard To's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hard To's price. Additionally, you may evaluate how the addition of Hard To to your portfolios can decrease your overall portfolio volatility.